Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - a case study workflow for in vitro-in vivo predictions.

[1]  G. Garbacz,et al.  PhysioCell^®; — a Novel, Bio-relevant Dissolution Apparatus: Hydrodynamic Conditions and Factors Influencing the Dissolution Dynamics , 2023, AAPS PharmSciTech.

[2]  S. Onoue,et al.  Quantitative assessment of disintegration rate is important for predicting the oral absorption of solid dosage forms containing poorly soluble weak base drugs. , 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  S. Kollipara,et al.  Utility of Physiologically Based Biopharmaeutics Modeling (PBBM) in Regulatory Approval: Application to Supersede f2, Enabling Biowaivers & Creation of Dissolution Safe Space. , 2022, Journal of pharmaceutical sciences.

[4]  Vidula Kolhatkar,et al.  The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives , 2022, Pharmaceutical Research.

[5]  P. Marroum,et al.  Physiologically based pharmacokinetic modeling and simulations to inform dissolution specifications and clinical relevance of release rates on elagolix exposure , 2022, Biopharmaceutics & drug disposition.

[6]  N. Patel,et al.  Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling , 2022, The AAPS journal.

[7]  J. Dressman,et al.  Towards virtual bioequivalence studies for oral dosage forms containing poorly water-soluble drugs: a physiologically based biopharmaceutics modeling (PBBM) approach. , 2021, Journal of pharmaceutical sciences.

[8]  G. Garbacz,et al.  Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial , 2021, Pharmaceutics.

[9]  Clive G. Wilson,et al.  Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  D. Danielak.  Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients? , 2021, Expert opinion on pharmacotherapy.

[11]  Gretchen A. Stevens,et al.  Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants , 2020, The Lancet.

[12]  J. Lulek,et al.  Physiologically Based Dissolution Testing in a Drug Development Process—a Case Study of a Successful Application in a Bioequivalence Study of Trazodone ER Formulations Under Fed Conditions , 2020, AAPS PharmSciTech.

[13]  W. Weitschies,et al.  Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  W. Weitschies,et al.  Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions , 2019, Pharmaceutics.

[15]  F. Kong,et al.  Development of a Gastric Simulation Model (GSM) incorporating gastric geometry and peristalsis for food digestion study. , 2019, Food research international.

[16]  Clive G. Wilson,et al.  Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  D Dupont,et al.  Can dynamic in vitro digestion systems mimic the physiological reality? , 2019, Critical reviews in food science and nutrition.

[18]  Michael Grimm,et al.  Low dose caffeine as a salivary tracer for the determination of gastric water emptying in fed and fasted state: A MRI validation study , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  L. Crane,et al.  A mathematical analysis of drug dissolution in the USP flow through apparatus , 2018 .

[20]  J. Dohnal,et al.  Optimization of Dissolution Compartments in a Biorelevant Dissolution Apparatus Golem v2, Supported by Multivariate Analysis , 2017, Molecules.

[21]  Michael Grimm,et al.  Gastric Water Emptying under Fed State Clinical Trial Conditions Is as Fast as under Fasted Conditions. , 2017, Molecular pharmaceutics.

[22]  Michael Grimm,et al.  Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers. , 2016, Advanced drug delivery reviews.

[23]  W. Weitschies,et al.  Dissolution of mesalazine modified release tablets under standard and bio‐relevant test conditions , 2015, The Journal of pharmacy and pharmacology.

[24]  K. Kamiński,et al.  The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations , 2015, AAPS PharmSciTech.

[25]  Martin C Garnett,et al.  Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. , 2014, Molecular pharmaceutics.

[26]  W. Weitschies,et al.  Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  H. Naik,et al.  Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals , 2014, Basic & clinical pharmacology & toxicology.

[28]  Erik Sjögren,et al.  In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Jennifer Dressman,et al.  Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in‐vivo performance of solid oral dosage forms , 2013, The Journal of pharmacy and pharmacology.

[30]  M. Kataoka,et al.  Measurement of Drug Concentration in the Stomach After Intragastric Administration of Drug Solution to Healthy Volunteers: Analysis of Intragastric Fluid Dynamics and Drug Absorption , 2013, Pharmaceutical Research.

[31]  A. Højer,et al.  The Clinical Pharmacokinetics of Lu AA21004 and its Major Metabolite in Healthy Young Volunteers , 2012, Basic & clinical pharmacology & toxicology.

[32]  Jan Tack,et al.  The migrating motor complex: control mechanisms and its role in health and disease , 2012, Nature Reviews Gastroenterology &Hepatology.

[33]  Zhenhua Tang,et al.  Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation development. , 2010, Molecular pharmaceutics.

[34]  A. Healy,et al.  Hydrodynamic and Species Transfer Simulations in the USP 4 Dissolution Apparatus: Considerations for Dissolution in a Low Velocity Pulsing Flow , 2010, Pharmaceutical Research.

[35]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  James C. Sexton,et al.  Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus , 2008, AAPS PharmSciTech.

[37]  A. Urtti,et al.  Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  Kiyohiko Sugano,et al.  Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test , 2006, Pharmaceutical Research.

[39]  L. D. Bradford,et al.  CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. , 2002, Pharmacogenomics.